Browse > Article

A Case of Subungal Abscess and Onycholysis Induced by Docetaxel  

Jung, Han Young (Department of Internal Medicine, The Yonsei University College of Medicine)
Lee, Chang Youl (Department of Internal Medicine, The Yonsei University College of Medicine)
Kim, Hyung Jung (Department of Internal Medicine, The Yonsei University College of Medicine)
Ahn, Chul Min (Department of Internal Medicine, The Yonsei University College of Medicine)
Chang, Yoon Soo (Department of Internal Medicine, The Yonsei University College of Medicine)
Publication Information
Tuberculosis and Respiratory Diseases / v.62, no.2, 2007 , pp. 125-128 More about this Journal
Abstract
Docetaxel is a taxoid antineoplastic drug, which is widely used to treat locally advanced or metastatic non-small cell lung cancer (NSCLC). Among the adverse dermatological reactions, nail disorders such as bending, onycholysis, hypoor hyperpigmentation are rare. We report a case of a 62-year-old male with advanced NSCLC (cT4N3M1, stage IV), who developed purulent discharge and onycholysis in the nail of all his fingers and the left great toe after five courses of anti-neoplastic chemotherapy, which included docetaxel (cumulative dose: $370mg/m^2$, 590 mg). Seven days after the final session of chemotherapy, the patient had become aware of discoloration and swelling of the nail beds with out pain. Three days later, greenish-yellow purulent discharge oozed out from the involved nails. Microbiologic studies revealed Pseudomonas aeruginosa. Intravenous and topical antibiotics (mupirocin) were applied. After 2 weeks, regrown nails were observed and the onycholysis had improved.
Keywords
Docetaxel; Onycholysis; Subungal abscess;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Minisini AM, Tosti A, Sobrero AF, Mansutti M, Piraccini BM, Sacco C, et al. Taxane-induced nail changes: incidence, clinical presentation and outcome. Ann Oncol 2003;14:333-7   DOI   ScienceOn
2 Correia O, Azevedo C, Pinto Ferreira E, Braga Cruz F, Polonia J. Nail changes secondary to docetaxel (Taxotere). Dermatology 1999;198:288-90   DOI   ScienceOn
3 Miller VA, Krug LM, Ng KK, Pizzo B, Perez W, Heelan RT, et al. Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer. J Clin Oncol 2000;18:1346-50   DOI
4 Obermair A, Binder M, Barrada M, Bancher-Todesca D, Asseryanis E, Kubista E. Onycholysis in patients treated with docetaxel. Ann Oncol 1998;9:230-1   DOI
5 Moisidis C, Mobus V. Erythema multiforme major following docetaxel. Arch Gynecol Obstet 2005;271: 267-9
6 Janinis J, Papadakou M, Panagos G, Panousaki A, Georgoulias V, Hatzidaki D, et al. Sequential chemo-radiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer. Am J Clin Oncol 2001;24:227-31   DOI   ScienceOn
7 Wasner G, Hilpert F, Schattschneider J, Binder A, Pfisterer J, Baron R. Docetaxel-induced nail changes: a neurogenic mechanism: a case report. J Neurooncol 2002;58:167-74   DOI   ScienceOn
8 Almagro M, Pozo JD, Garcia J, Vasquez A, Fonseca E. Nail alterations secondary to paclitaxel therapy. Eur J Dermatol 2000;10:146-7
9 Nicolopoulos J, Howard A. Docetaxel-induced nail dystrophy. Australas J Dermatol 2002;43:293-6   DOI   ScienceOn
10 Vanhooteghem O, Andre J, Vindevoghel A, Vandenbossche L, Vandeveire A, Song M. Docetaxel-induced subungal hemorrhage. Dermatology 1997;194:419-20   DOI   ScienceOn
11 Lee MS, Kim HO, Park YM. A case of subungal abscess and onycholysis related to docetaxel. Korean J Dermatol 2003;41:1393-5
12 Scotte F, Tourani JM, Banu E, Peyromaure M, Levy E, Marsan S, et al. Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand. J Clin Oncol 2005;23: 4424-9   DOI   ScienceOn
13 Tinio P, Bershad S, Levitt JO. Docetaxel-induced onycholysis. J Am Acad Dermatol 2005;52:350-1   DOI   ScienceOn
14 Jones R, Ryan M, Friedlander M. Carboplatin hypersensitivity reactions: retreatment with cisplatin desensitisation. Gynecol Oncol 2003;89:112-5   DOI   ScienceOn